Moderna’s Covid-19 Vaccine Targeting Omicron Produces Stronger Immune Response

日本 ニュース ニュース

Moderna’s Covid-19 Vaccine Targeting Omicron Produces Stronger Immune Response
日本 最新ニュース,日本 見出し
  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 53%

A new Moderna Covid-19 vaccine works better than the company’s current vaccine against the Omicron variant, a study found. The new vaccine targets both Omicron and the original strain of the virus.

Experimental vaccine, designed to fight Omicron and original virus, found to be more effective against new variant than current shot

If you’ve had Covid before, why can you get it again? WSJ’s Daniela Hernandez explains what the possibility of reinfections means for the future of public-health policy and the Covid-19 pandemic. Illustration: David FangInc. said a modified Covid-19 booster shot provided a stronger immune response than the company’s originalThe Cambridge, Mass., company said Wednesday it will submit preliminary data from the study to U.S.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

WSJhealth /  🏆 413. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Novavax hoping its COVID-19 vaccine using traditional technology wins over vaccine skepticsNovavax hoping its COVID-19 vaccine using traditional technology wins over vaccine skepticsThe Novavax COVID-19 vaccine is made with an old school technology, but will it be enough to win over vaccine skeptics?
続きを読む »

FDA panel recommends Novavax COVID-19 vaccine be the fourth allowed for use in USFDA panel recommends Novavax COVID-19 vaccine be the fourth allowed for use in USThe vaccine, which was supported by $1.8 billion in taxpayer funding, uses a more traditional approach than some other COVID-19 vaccines allowed in the USA.
続きを読む »

FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's NovavaxFDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's NovavaxDevelopment of the vaccine, from Novavax, a Gaithersburg, Maryland-based company, was started at the same time as others in 2020, but the company struggled to produce its shot in large quantities.
続きを読む »

What Our COVID-19 Response Can Teach Us About Containing MonkeypoxWhat Our COVID-19 Response Can Teach Us About Containing MonkeypoxAfter over two years fighting COVID-19, we should have the the tools to contain monkeypox—but only if we learn from previous mistakes.
続きを読む »

Burien ends emergency hazard pay for grocery workers, citing a shift in the pandemicBurien ends emergency hazard pay for grocery workers, citing a shift in the pandemicBurien City Council leaders announced the end of emergency hazard pay for grocery workers on Monday, citing readily available COVID-19 vaccines and boosters as a major turning point in the pandemic. FOX13
続きを読む »

US has wasted more than 82 million COVID-19 vaccine doses: reportUS has wasted more than 82 million COVID-19 vaccine doses: reportMillions of COVID-19 vaccine doses have been discarded during the pandemic as the Biden administration urges Americans to get booster shots
続きを読む »



Render Time: 2025-03-06 17:41:28